NIH: Pharma Sales Department
The National Institutes of Health should no longer be considered a public health agency. It’s a profit machine — one that takes a cut from the very drugs it’s supposed to objectively evaluate.
According to Robert F. Kennedy Jr., individuals who work at NIH collect royalties on pharmaceutical products they help develop.
The people supposedly protecting public health are cashing in on the industry they’re meant to regulate.
The Moderna COVID-19 vaccine? NIH owns 50% of it. And they didn’t just approve it — they promoted it. Heavily. Because they stood to make billions. That’s not science. That’s sales.
RFK Jr. is blunt: “NIH has become an incubator for pharmaceutical products.”
Not a research hub. Not a defender of public health. An incubator — churning out patents and profits instead of answers.
It’s not asking why chronic illness is skyrocketing in America. It won’t. Because doing so might point the finger back at the corporations they’re in bed with.
America is sick
The sickest developed nation in the world, by nearly every measure is America.
Autism rates have exploded — from 1 in 10,000 in Kennedy’s generation to 1 in 34 today. One in every three children is diabetic or pre-diabetic. Allergies that were virtually unheard of in the 1980s — like peanut allergies — are now widespread and life-threatening.
Where is the urgency to find out why?
There isn’t any, not from governing bodies anyway. Because looking too closely means risking the wrath of powerful industries: Big Pharma, Big Food, Big Ag, Big Chem. NIH doesn’t want that fight — it wants royalties.
What changed in the 1980s and 90s? The mass introduction of high-fructose corn syrup. The surge in glyphosate use (Roundup). The rise of neonicotinoid pesticides. The flood of endocrine disruptors and “forever chemicals” in consumer products.
Each one of these suspects is worth investigating. NIH has chosen not to — because these industries are too profitable to challenge.
This is regulatory capture at its most insidious. The institutions meant to serve the public have been repurposed into marketing arms for corporate America. NIH isn’t looking for root causes. It’s too busy monetizing treatments for the symptoms.
Kennedy’s promise — to force the agency to ask the right questions and follow the evidence, no matter where it leads — should be the bare minimum. But in today’s captured system, it’s revolutionary.
